GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Ending Cash Position

INDV (Indivior) Ending Cash Position : $372 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Indivior Ending Cash Position?

Indivior's Ending Cash Position for the quarter that ended in Mar. 2025 was $372 Mil.

Indivior's quarterly Ending Cash Position increased from Sep. 2024 ($288 Mil) to Dec. 2024 ($319 Mil) and increased from Dec. 2024 ($319 Mil) to Mar. 2025 ($372 Mil).

Indivior's annual Ending Cash Position declined from Dec. 2022 ($774 Mil) to Dec. 2023 ($316 Mil) but then increased from Dec. 2023 ($316 Mil) to Dec. 2024 ($319 Mil).

Indivior Ending Cash Position Historical Data

The historical data trend for Indivior's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Ending Cash Position Chart

Indivior Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 858.00 1,102.00 774.00 316.00 319.00

Indivior Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 248.00 302.00 288.00 319.00 372.00

Indivior Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Indivior's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=316+3
=319

Indivior's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=319+53
=372

Indivior Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Indivior's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Indivior Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Ending Cash Position
Comparable Companies
LSE:APH LSE:AGY LSE:ANCR LSE:HCM LSE:EAH LSE:STX AQSE:ANA LSE:PXS LSE:CEL LSE:N4P ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
INDVl:UK INDV:UK 2IVB:Germany 2IVB:Germany
Address
10710 Midlothian Turnpike, Suite 125, North Chesterfield, Richmond, VA, USA, 23235
Website
https://www.indivior.com
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.